Sign Up for a Free Account
  • Updated 03.01.2021
  • Released 01.20.2000
  • Expires For CME 03.01.2024

Levetiracetam

Introduction

Historical note and terminology

Levetiracetam is a pyrrolidone derivative and not related to any of the antiepileptic drugs currently in use. It has been approved by the Food and Drug Administration in the United States and in the European Union and various other countries. Although levetiracetam is more expensive than traditional antiepileptic drugs, its cost is comparable to that of newer antiepileptic drugs.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com